NCT03269474View on ClinicalTrials.gov

Computational Drug Repurposing for All EBS Cases

RecruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

November 28, 2017

Primary Completion Date

December 30, 2024

Study Completion Date

December 31, 2024

Conditions
Epidermolysis BullosaHealthyGenetic Skin DiseaseEpidermolysis Bullosa SimplexEpidermolysis Bullosa, JunctionalEpidermolysis Bullosa Dystrophica
Interventions
PROCEDURE

Experimental Group

Subjects with EB diagnosis

Trial Locations (1)

94304

RECRUITING

Pediatric Dermatology Clinic at Stanford Children's Hospital, Palo Alto

All Listed Sponsors
lead

Joyce Teng

OTHER